Clinical trials
Cardiovascular Diseases trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
82 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 4 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 10 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 9 |
| 2021 | 10 |
| 2022 | 7 |
| 2023 | 9 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 82 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Institute of Heart, Lung and Blood Vessel Diseases | 5 |
| China National Center for Cardiovascular Diseases | 5 |
| Xijing Hospital | 3 |
| Chinese PLA General Hospital | 2 |
| First Hospital of China Medical University | 2 |
| Fudan University | 2 |
| Guangdong Provincial People's Hospital | 2 |
| Huazhong University of Science and Technology | 2 |
| MicroPort NeuroTech Co., Ltd. | 2 |
| Nanfang Hospital, Southern Medical University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 82 |
| Coronary Artery Disease | 7 |
| Heart Failure | 7 |
| Vascular Diseases | 7 |
| Coronary Disease | 6 |
| Hypertension | 6 |
| Myocardial Ischemia | 6 |
| Stroke | 6 |
| Diabetes Mellitus | 5 |
| Heart Diseases | 5 |
Trials
Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.